Company: PETVW
Filing Date: 2025-02-14
Form Type: 10-Q
Source: 0001493152-25-006783
Chunk: 38

Company: PetVivo Holdings, Inc.
Filing Date: 2025-02-14
Form: 10-Q
Item: Part I, Item 1
Chunk 38
---
 March 31, 2024, and the nine months ended
December 31, 2024, respectively.

Options
exercisable at December 31, 2024, had exercise prices ranging from $1.39 to $2.79.

The
following summarizes additional information about our stock options:

 SCHEDULE OF ADDITIONAL INFORMATION ABOUT STOCK OPTIONS

    Nine Months Ended 
    Year Ended

    December 31, 2024 
    Mar 31, 2024
  
    Number of: 

    Non-vested options, beginning of period 
     936,707  
     709,394 
  
    Non -vested options, end of period 
     709,136  
     936,707 
  
    Vested options, end of period 
     310,742  
     572,415 

    Nine Months Ended 
    Year Ended

    December 31, 2024 
    Mar 31, 2024
  
    Weighted-average grant date fair value of: 

    Non-vested options, beginning of period 
    $1.84  
    $2.23 
  
    Non-vested options, end of period 
    $1.57  
    $1.84 
  
    Vested options, end of period 
    $2.31  
    $2.21 
  
    Forfeited options, during the period 
    $1.87  
    $2.03 

Warrants

During
the nine months ended December 31, 2024, the Company issued warrants to purchase an aggregate of 5,365,232 shares of common stock in
connection with the sale of stock in a private offering.

These
warrants’ values were arrived at by using the Black-Scholes valuation model with the following assumptions:

 SCHEDULE OF WARRANT’S USING BLACK-SCHOLES VALUATION

    Nine Months Ended

    December 31, 2024
  
    Stock price on valuation date 
    $0.49 - $0.82  
  
    Exercise price 
    $0.90 - $1.50 
  
    Term (years) 
     3.0 
  
    Volatility 
     92.7% - 95.3%
  
    Risk-free rate 
     4.02% - 4.15%

The
Company did not issue any warrants for the nine